Antidepressants and mental health medications

Specialty excipients/film-coatings for pharma (Opadry, Methocel-based systems, modified-release polymers); formulation partner for ER/abuse-deterrent tablets.

China's largest fluorochemical producer; manufactures fluorination intermediates used as KSMs for SSRIs (sertraline, fluoxetine, escitalopram) and other fluorine-containing pharmaceuticals

Indian pharmaceutical API manufacturer (NSE: DIVISLAB, HQ Hyderabad; ~₹75B revenue); one of India's largest and most technically sophisticated pharmaceutical API producers, specializing in complex APIs including fluoroquinolones (ciprofloxacin, ofloxacin, levofloxacin), carotenoids (nutraceuticals), and custom synthesis for branded pharmaceutical companies. Divi's Laboratories has never been involved in a major USFDA warning letter or import alert (unusual for an Indian API company of its scale) — maintaining essentially clean regulatory compliance across its multiple Visakhapatnam, Andhra Pradesh production facilities. Divi's produces fluoroquinolone APIs including ciprofloxacin HCl for ophthalmic applications for global generic pharmaceutical customers. Divi's is also one of India's most consistently profitable pharmaceutical companies — its focus on volume API production at high quality has created a near-uninterruptible supply chain position across multiple essential medicines.

World's largest supplier of azithromycin API for regulated markets. TAPI is Teva's dedicated API business supplying both Teva's own generics and third-party manufacturers.

Chinese pharmaceutical company (HKEX: 1093, HQ Shijiazhuang Hebei; ~HKD 30B revenue); one of China's largest cephalosporin API and finished dose pharmaceutical manufacturers. CSPC produces 7-ACA, cephalosporin APIs (cephalexin, ceftriaxone, cefazolin), and downstream finished dose cephalosporin antibiotics for domestic and export markets. CSPC's Zhongrun Division is one of China's largest cephalosporin API producers. CSPC is headquartered in Shijiazhuang, Hebei — the same city as NCPC (North China Pharmaceutical), making Shijiazhuang the world's most concentrated antibiotic API manufacturing city. Hebei Province collectively produces a dominant fraction of global penicillin, cephalosporin, and other antibiotic APIs.

World's fourth-largest specialty generic pharma company and India's largest by market cap; major global supplier of psychiatric generics including antidepressants and antipsychotics

India's second-largest pharma company by revenue; major manufacturer of SSRIs, antipsychotic APIs, and finished formulations for the US and EU markets

Zhejiang Medicine Co., Ltd. (Shaoxing, Zhejiang China; SZSE: 000989) is China's largest Vitamin E manufacturer (world's #2) and a major producer of steroid hormone KSMs used in pharmaceutical synthesis. Zhejiang Medicine's steroid intermediate products (including diosgenin-derived pregnenolone, progesterone, and dehydroepiandrosterone) are upstream KSMs for corticosteroids (prednisone, dexamethasone, triamcinolone) — the anti-inflammatory drugs used across rheumatoid arthritis, asthma, COVID-19 treatment, transplant rejection, and oncology. Zhejiang Medicine also produces Vitamin A, Vitamin D3, and carotenoids — key nutritional KSMs for pharmaceutical and food supplement applications. The company represents the dual nature of Chinese pharmaceutical precursor dominance: food supplement vitamins and pharmaceutical steroids made in the same Zhejiang province chemical industrial base.

US generic pharmaceutical company (spun off from Pfizer/Mylan 2020); first FDA approval for generic Restasis (cyclosporine ophthalmic emulsion) February 2022.

Indian multinational pharmaceutical company (NSE: DRREDDY; HQ Hyderabad) with significant irinotecan API and finished dose manufacturing. Dr. Reddy's manufactures irinotecan hydrochloride injection for the U.S. and European generic markets — one of the leading generic irinotecan suppliers approved by FDA and EMA. The company converts camptothecin (procured primarily from Chinese botanical extraction sources) into irinotecan API via semi-synthesis at its Hyderabad API facilities. Dr. Reddy's broader oncology generics franchise includes paclitaxel, docetaxel, and topotecan, making it one of the few Indian companies with a full camptothecin-class API portfolio. Supply of irinotecan to the U.S. critical care oncology market is a significant part of the company's FDA-regulated generic pharmaceutical business.

Major Chinese API manufacturer supplying psychiatric and cardiovascular APIs globally; received FDA warning letter in 2018 after NDMA contamination in its valsartan API

Blow-molder of HDPE/PET bottles & jars for pharma, nutritional and personal-care markets.

Berry Global Group, Inc. (Evansville IN; NYSE: BERY; ~$13B revenue) is one of the world's largest manufacturers of nonwoven fabrics and plastic packaging. Berry's Nonwoven Specialties segment (including Reemay, Avgol, and Fiberweb brands acquired over 2014-2019) operates meltblown, spunbond, and SMS (spunbond-meltblown-spunbond) lines globally. Berry acquired Avgol Nonwovens (Israel/China/India) in 2019 for $430M, making it the world's second-largest hygiene nonwoven producer. Key meltblown facilities: Carlisle UK, Biesheim France, Clervaux Luxembourg, Mooresville NC, and multiple Asian sites. Berry supplies meltblown filtration fabric for N95 respirators, HVAC filters, surgical drapes, and automotive cabin air filters. Dual-use across healthcare, hygiene, and industrial filtration.

Specialty pharmaceutical-grade lactose company (HQ Goch, Germany; joint venture between Fonterra Co-operative Group and FrieslandCampina); the world's largest producer of pharmaceutical-grade lactose for use as a drug excipient in tablets, capsules, and dry powder inhalers. DFE Pharma's lactose (Pharmatose® brand) is used in the vast majority of pharmaceutical tablet and capsule formulations globally — most pills you take contain DFE Pharma lactose as a filler, flow agent, or binder. DFE Pharma's manufacturing combines Fonterra (NZ) lactose raw material expertise with FrieslandCampina (NL) processing capability. The same Fonterra-FrieslandCampina lactose joint venture that makes the excipient in most of the world's pharmaceutical tablets also produces food-grade lactose for infant formula.

Specialist maker of HDPE pharmaceutical bottles and child-resistant closures for Rx/OTC drugs.

German pharma packaging specialist; ~30–35% global pharma glass packaging alongside Schott; acquired Bormioli Pharma Dec 2024; also produces LDPE ophthalmic dropper bottles (System A).

F&F major (~20% global share); Nouryon acquisition brought enzymes and surfactant inputs.

Cellulose-based excipient maker; microcrystalline cellulose (Vivapur), disintegrants and binders for tablets.